Abstract |
Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the United States population. This guideline addresses important clinical questions that arise in psoriasis management and care and provides recommendations based on the available evidence. The treatment of psoriasis with topical agents and with alternative medicine will be reviewed, emphasizing treatment recommendations and the role of dermatologists in monitoring and educating patients regarding benefits as well as risks that may be associated. This guideline will also address the severity assessment methods of psoriasis in adults.
|
Authors | Craig A Elmets, Neil J Korman, Elizabeth Farley Prater, Emily B Wong, Reena N Rupani, Dario Kivelevitch, April W Armstrong, Cody Connor, Kelly M Cordoro, Dawn M R Davis, Boni E Elewski, Joel M Gelfand, Kenneth B Gordon, Alice B Gottlieb, Daniel H Kaplan, Arthur Kavanaugh, Matthew Kiselica, Daniela Kroshinsky, Mark Lebwohl, Craig L Leonardi, Jason Lichten, Henry W Lim, Nehal N Mehta, Amy S Paller, Sylvia L Parra, Arun L Pathy, Michael Siegel, Benjamin Stoff, Bruce Strober, Jashin J Wu, Vidhya Hariharan, Alan Menter |
Journal | Journal of the American Academy of Dermatology
(J Am Acad Dermatol)
Vol. 84
Issue 2
Pg. 432-470
(Feb 2021)
ISSN: 1097-6787 [Electronic] United States |
PMID | 32738429
(Publication Type: Journal Article, Practice Guideline)
|
Copyright | Copyright © 2020 American Academy of Dermatology, Inc. All rights reserved. |
Chemical References |
|
Topics |
- Academies and Institutes
(standards)
- Administration, Cutaneous
- Combined Modality Therapy
(methods, standards)
- Complementary Therapies
(methods, standards)
- Dermatologic Agents
(administration & dosage)
- Dermatology
(methods, standards)
- Evidence-Based Medicine
(methods, standards)
- Foundations
(standards)
- Humans
- Patient Education as Topic
(standards)
- Psoriasis
(diagnosis, therapy)
- Severity of Illness Index
- Treatment Outcome
- United States
|